Literature DB >> 15483403

Chk1 versus Cdc25: chking one's levels of cellular proliferation.

Michael H Lam1, Jeffrey M Rosen.   

Abstract

This review summarizes recent studies which have provided new insight into the mechanisms by which the DNA damage response kinase, Chk1 inhibits the dual specificity phosphatase, Cdc25, and thereby regulates cell cycle progression. Recently, Chk1 has been shown to not only regulate Cdc25A degradation but also its ability to interact with various Cdk complexes through phosphorylation of the carboxy-terminus of the phosphatase. Surprisingly, these effects appear to be specific for Chk1, but not Chk2, which may explain the recently reported in vivo haploinsufficiency phenotype observed in the mammary gland using a Chk1 conditional mouse model.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15483403     DOI: 10.4161/cc.3.11.1225

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  13 in total

1.  Lithium causes G2 arrest of renal principal cells.

Authors:  Theun de Groot; Mohammad Alsady; Marcel Jaklofsky; Irene Otte-Höller; Ruben Baumgarten; Rachel H Giles; Peter M T Deen
Journal:  J Am Soc Nephrol       Date:  2014-01-09       Impact factor: 10.121

2.  ATP depletion triggers acute myeloid leukemia differentiation through an ATR/Chk1 protein-dependent and p53 protein-independent pathway.

Authors:  Amitabha Chakrabarti; Kalpana Gupta; James Prabhakar Sharma; Jinbo Yang; Anju Agarwal; Abigail Glick; Youwei Zhang; Munna Agarwal; Mukesh K Agarwal; David N Wald
Journal:  J Biol Chem       Date:  2012-05-23       Impact factor: 5.157

3.  Evaluation of the DNA damaging potential of indigenous health hazardous quartz nanoparticles on the cultured lung cells.

Authors:  Hridyesh Kumar; Iqbal Ahmad; Pradip Kumar Dutta
Journal:  Toxicol Res (Camb)       Date:  2016-12-20       Impact factor: 3.524

4.  Chk1 phosphorylates the tumour suppressor Mig-6, regulating the activation of EGF signalling.

Authors:  Ning Liu; Masaki Matsumoto; Kyoko Kitagawa; Yojiro Kotake; Sayuri Suzuki; Senji Shirasawa; Keiichi I Nakayama; Makoto Nakanishi; Hiroyuki Niida; Masatoshi Kitagawa
Journal:  EMBO J       Date:  2012-04-13       Impact factor: 11.598

5.  The Chk1/Cdc25A pathway as activators of the cell cycle in neuronal death induced by camptothecin.

Authors:  Yi Zhang; Dianbo Qu; Erick J Morris; Michael J O'Hare; Steven M Callaghan; Ruth S Slack; Herbert M Geller; David S Park
Journal:  J Neurosci       Date:  2006-08-23       Impact factor: 6.167

Review 6.  The substrates of Plk1, beyond the functions in mitosis.

Authors:  X Shawn Liu; Bing Song; Xiaoqi Liu
Journal:  Protein Cell       Date:  2010-12-10       Impact factor: 14.870

7.  BCL6 represses CHEK1 and suppresses DNA damage pathways in normal and malignant B-cells.

Authors:  Stella M Ranuncolo; Jose M Polo; Ari Melnick
Journal:  Blood Cells Mol Dis       Date:  2008-03-17       Impact factor: 3.039

Review 8.  Molecular Pathways: Targeting ATR in Cancer Therapy.

Authors:  Larry M Karnitz; Lee Zou
Journal:  Clin Cancer Res       Date:  2015-09-11       Impact factor: 12.531

9.  Novel intestinal splice variants of RNA-binding protein CUGBP2: isoform-specific effects on mitotic catastrophe.

Authors:  Satish Ramalingam; Gopalan Natarajan; Chris Schafer; Dharmalingam Subramaniam; Randal May; Ilangovan Ramachandran; Lurdes Queimado; Courtney W Houchen; Shrikant Anant
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-02-07       Impact factor: 4.052

10.  Toxic effect of silica nanoparticles on endothelial cells through DNA damage response via Chk1-dependent G2/M checkpoint.

Authors:  Junchao Duan; Yongbo Yu; Yang Li; Yang Yu; Yanbo Li; Xianqing Zhou; Peili Huang; Zhiwei Sun
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.